Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Dotinurad (Urece) is a drug for the treatment of gout and hyperuricemia. It was developed by Fuji Yakuhin and approved for use in Japan in 2020, and in China in 2024. The drug is continuing clinical trials by Fortress Biotech and regulatory evaluation for approval in North America and Europe.
Regions & Overview
Explore the main themes, entities and connections around Dotinurad. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
drug urece gout hyperuricemia developed uricosuric urat1 slc22a12 epaminurad benzbromarone treatment fuji yakuhin approved use japan 2020 china 2024 continuing
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Dotinurad | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Dotinurad | ATC code | M04AB06 (WHO) | 1.00 | infobox |
| Dotinurad | CAS Number | 1285572-51-1 | 1.00 | infobox |
| Dotinurad | ChEMBL | ChEMBL4594446 | 1.00 | infobox |
| Dotinurad | ChemSpider | 59718651 | 1.00 | infobox |
| Dotinurad | DrugBank | DB16145 | 1.00 | infobox |
| Dotinurad | Formula | C14H9Cl2NO4S | 1.00 | infobox |
| Dotinurad | KEGG | D11071 | 1.00 | infobox |
| Dotinurad | Legal status | JP: Rx-only | 1.00 | infobox |
| Dotinurad | Molar mass | 358.19 g·mol−1 | 1.00 | infobox |
| Dotinurad | Other names | FYU-981 | 1.00 | infobox |
| Dotinurad | PubChem CID | 51349053 | 1.00 | infobox |
| Dotinurad | Trade names | Urece | 1.00 | infobox |
| Dotinurad | UNII | 305EB53128 | 1.00 | infobox |
| Dotinurad | is a | uricosuric that acts as a selective urate reabsorption inhibitor that has uric acid lowering activity by inhibiting URAT1/SLC22A12 receptor | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.